References 1-50

  1. Cancer Facts & Figures 2020.
  2. Cancer Health Disparities Definitions – National Cancer Institute [Internet]. [cited 2019 Jun 19]. Available from:
  3. Arteaga CL, Adamson PC, Engelman JA, Foti M, Gaynor RB, Hilsenbeck SG, et al. AACR Cancer Progress Report 2014. Clin Cancer Res [Internet]. 2014;20:S1 LP-S112. Available from:
  4. Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ CK (eds). SEER Cancer Statistics Review, 1975-2016, National Cancer Institute. Bethesda, MD. Based on November 2018 SEER data submission, posted to the SEER web site, April 2019. [cited 2019 Jun 19]; Available from:
  5. American Cancer Society. Cancer Facts & Figures for Hispanics / Latinos 2018-2020. 2018;42.
  6. Siegel RL, Miller KD. Cancer Statistics, 2019. 2019;69:7–34.
  7. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin [Internet]. 2020; Available from:
  8. Jaffe SA, Myers O, Meisner ALW, Wiggins CL, Hill DA, McDougall JA. Relationship between Insurance Type at Diagnosis and Hepatocellular Carcinoma Survival. 2020;1–9.
  9. Gonzales G, Zinone R. Cancer diagnoses among lesbian, gay, and bisexual adults: results from the 2013–2016 National Health Interview Survey. Cancer Causes Control [Internet]. 2018 [cited 2019 Jun 19];29:845–54. Available from:
  10. Management OOF. Federal Register. Fed Regist. 2010;75:56928–35.
  11. WHO | Equity. WHO [Internet]. World Health Organization; 2016 [cited 2020 Jan 22]; Available from:
  12. DeSantis CE, Miller KD, Goding Sauer A, Jemal A, Siegel RL. Cancer statistics for African Americans, 2019. CA Cancer J Clin [Internet]. 2019 [cited 2019 Feb 15]; Available from:
  13. Bureau UC. National Population by Characteristics: 2010-2019. [cited 2020 Jan 22]; Available from:
  14. Mahal BA, Berman RA, Taplin M-E, Huang FW. Prostate Cancer–Specific Mortality Across Gleason Scores in Black vs Nonblack Men. JAMA [Internet]. American Medical Association; 2018 [cited 2019 Dec 11];320:2479. Available from:
  15. Grad YH, Lipsitch M, Aiello AE. Secular Trends in Helicobacter pylori Seroprevalence in Adults in the United States: Evidence for Sustained Race/Ethnic Disparities. Am J Epidemiol [Internet]. 2012 [cited 2019 Dec 11];175:54–9. Available from:
  16. Fiala MA, Wildes TM. Racial disparities in treatment use for multiple myeloma. Cancer. United States; 2017;123:1590–6.
  17. Carethers JM, Doubeni CA. Causes of Socioeconomic Disparities in Colorectal Cancer and Intervention Framework and Strategies. Gastroenterology [Internet]. 2020 [cited 2020 Jan 22];158:354–67. Available from:
  18. White A, Thompson TD, White MC, Sabatino SA, Moor J de, Doria-Rose P V., et al. Cancer screening test use — United States, 2015. Morb Mortal Wkly Rep [Internet]. 2017;66:201–6. Available from:
  19. Lansdorp-Vogelaar I, Kuntz KM, Knudsen AB, van Ballegooijen M, Zauber AG, Jemal A. Contribution of screening and survival differences to racial disparities in colorectal cancer rates. Cancer Epidemiol Biomarkers Prev [Internet]. NIH Public Access; 2012 [cited 2019 Dec 11];21:728–36. Available from:
  20. Thornton JG, Morris AM, Thornton JD, Flowers CR, McCashland TM. Racial variation in colorectal polyp and tumor location. J Natl Med Assoc [Internet]. 2007 [cited 2019 Dec 11];99:723–8. Available from:
  21. Lai Y, Wang C, Civan JM, Palazzo JP, Ye Z, Hyslop T, et al. Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study. Gastroenterology [Internet]. 2016 [cited 2019 Dec 11];150:1135–46. Available from:
  22. Breast Cancer Facts & Figures 2019-2020. Am Cancer Soc. 2019;70:515–7.
  23. U.S. Census Bureau QuickFacts: Puerto Rico [Internet]. [cited 2019 Dec 11]. Available from:
  24. Miller KD, Goding Sauer A, Ortiz AP, Fedewa SA, Pinheiro PS, Tortolero-Luna G, et al. Cancer Statistics for Hispanics/Latinos, 2018. CA Cancer J Clin [Internet]. 2018 [cited 2019 Dec 11];68:425–45. Available from:
  25. Zamora SM, Pinheiro PS, Gomez SL, Hastings KG, Palaniappan LP, Hu J, et al. Disaggregating Hispanic American Cancer Mortality Burden by Detailed Ethnicity. Cancer Epidemiol Biomarkers Prev [Internet]. 2019 [cited 2019 Dec 11];28:1353–63. Available from:
  26. Fejerman L, John EM, Huntsman S, Beckman K, Choudhry S, Perez-Stable E, et al. Genetic Ancestry and Risk of Breast Cancer among U.S. Latinas. Cancer Res [Internet]. 2008 [cited 2019 Dec 11];68:9723–8. Available from:
  27. Pinheiro PS, Sherman RL, Trapido EJ, Fleming LE, Huang Y, Gomez-Marin O, et al. Cancer Incidence in First Generation U.S. Hispanics: Cubans, Mexicans, Puerto Ricans, and New Latinos. Cancer Epidemiol Biomarkers Prev [Internet]. 2009 [cited 2019 Dec 11];18:2162–9. Available from:
  28. Stern MC, Fejerman L, Das R, Setiawan VW, Cruz-Correa MR, Perez-Stable EJ, et al. No Title. Springer; 2016 [cited 2019 Dec 11];3:181–90. Available from:
  29. Setiawan VW, Wei PC, Hernandez BY, Lu SC, Monroe KR, Le Marchand L, et al. No Title. Cancer [Internet]. NIH Public Access; 2016 [cited 2019 Dec 11];122. Available from:
  30. Ho GYF, Figueroa-Vallés NR, De La Torre-Feliciano T, Tucker KL, Tortolero-Luna G, Rivera WT, et al. Cancer disparities between mainland and island Puerto Ricans. Rev Panam Salud Publica [Internet]. 2009 [cited 2019 Dec 11];25:394–400. Available from:
  31. Pinheiro PS, Callahan KE, Siegel RL, Jin H, Morris CR, Trapido EJ, et al. Cancer Mortality in Hispanic Ethnic Groups. Cancer Epidemiol Biomarkers Prev [Internet]. 2017 [cited 2019 Dec 11];26:376–82. Available from:
  32. Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Fredua B, et al. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2018. MMWR Morb Mortal Wkly Rep [Internet]. 2019 [cited 2019 Dec 11];68:718–23. Available from:
  33. Bureau USC. American FactFinder. [cited 2019 Dec 11]; Available from:
  34. American Cancer Society. Facts & Figures 2019. Am Cancer Soc Atlanta, Ga. 2019.
  35. Cancer Facts & Figures 2016. Am Cancer Soc. 2011;122:532–5.
  36. Melkonian SC, Jim MA, Reilley B, Erdrich J, Berkowitz Z, Wiggins CL, et al. Incidence of primary liver cancer in American Indians and Alaska Natives, US, 1999-2009. Cancer Causes Control [Internet]. NIH Public Access; 2018 [cited 2019 Dec 11];29:833–44. Available from:
  37. White MC, Espey DK, Swan J, Wiggins CL, Eheman C, Kaur JS. Disparities in cancer mortality and incidence among American Indians and Alaska Natives in the United States. Am J Public Health [Internet]. American Public Health Association; 2014 [cited 2019 Dec 11];104 Suppl 3:S377-87. Available from:
  38. Health Disparities | DCCPS/NCI/NIH [Internet]. [cited 2019 Dec 16]. Available from:
  39. Singh GK, Daus GP, Allender M, Ramey CT, Martin EK, Perry C, et al. Social Determinants of Health in the United States: Addressing Major Health Inequality Trends for the Nation, 1935-2016. Int J MCH AIDS [Internet]. Global Health and Education Projects, Inc.; 2017 [cited 2019 Dec 16];6:139–64. Available from:
  40. Alcaraz KI, Wiedt TL, Daniels EC, Yabroff KR, Guerra CE, Wender RC. Understanding and addressing social determinants to advance cancer health equity in the United States: A blueprint for practice, research, and policy. CA Cancer J Clin [Internet]. 2020 [cited 2020 Jan 22];70:31–46. Available from:
  41. Kickbusch I, McCann W, Sherbon T. Healthy People 2020: An Opportunity to Address Societal Determinants of Health in the United States. Health Promot Int [Internet]. 2008 [cited 2019 Dec 16];23:1–4. Available from:
  42. Capturing Social and Behavioral Domains and Measures in Electronic Health Records [Internet]. Washington, D.C.: National Academies Press; 2014 [cited 2019 Dec 16]. Available from:
  43. Alley DE, Asomugha CN, Conway PH, Sanghavi DM. Accountable Health Communities — Addressing Social Needs through Medicare and Medicaid. N Engl J Med [Internet]. 2016 [cited 2019 Dec 16];374:8–11. Available from:
  44. Health Disparities Calculator (HD*Calc) – SEER Software [Internet]. [cited 2019 Dec 16]. Available from:
  45. Siegel RL, Jemal A, Wender RC, Gansler T, Ma J, Brawley OW. An assessment of progress in cancer control. CA Cancer J Clin [Internet]. American Cancer Society; 2018 [cited 2019 Dec 16];68:329–39. Available from:
  46. Index of Programs, Surveys, Demographic Tables [Internet]. [cited 2020 Jan 22]. Available from:
  47. Ransome E, Tong L, Espinosa J, Chou J, Somnay V, Munene G. Trends in surgery and disparities in receipt of surgery for intrahepatic cholangiocarcinoma in the US: 2005-2014. J Gastrointest Oncol [Internet]. AME Publications; 2019 [cited 2019 Jun 20];10:339–47. Available from:
  48. Yeboa DN, Xu X, Jones BA, Soulos P, Gross C, Yu JB. Trend in Age and Racial Disparities in the Receipt of Postlumpectomy Radiation Therapy for Stage I Breast Cancer: 2004-2009. Am J Clin Oncol. United States; 2016;39:568–74.
  49. Pan HY, Walker G V., Grant SR, Allen PK, Jiang J, Guadagnolo BA, et al. Insurance Status and Racial Disparities in Cancer-Specific Mortality in the United States: A Population-Based Analysis. Cancer Epidemiol Biomarkers Prev [Internet]. American Association for Cancer Research; 2017 [cited 2019 Dec 16];26:869–75. Available from:
  50. Niu X, Roche LM, Pawlish KS, Henry KA. Cancer survival disparities by health insurance status. Cancer Med [Internet]. Wiley-Blackwell; 2013 [cited 2019 Dec 16];2:403–11. Available from:

References 51-100

  1. Rong X, Yang W, Garzon-Muvdi T, Caplan JM, Hui X, Lim M, et al. Influence of insurance status on survival of adults with glioblastoma multiforme: A population-based study. Cancer [Internet]. John Wiley & Sons, Ltd; 2016 [cited 2019 Dec 16];122:3157–65. Available from:
  2. Markt SC, Lago-Hernandez CA, Miller RE, Mahal BA, Bernard B, Albiges L, et al. Insurance status and disparities in disease presentation, treatment, and outcomes for men with germ cell tumors. Cancer [Internet]. John Wiley & Sons, Ltd; 2016 [cited 2019 Dec 16];122:3127–35. Available from:
  3. Pezzi TA, Schwartz DL, Mohamed ASR, Welsh JW, Komaki RU, Hahn SM, et al. Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer. JAMA Oncol [Internet]. 2018 [cited 2019 Dec 16];4:e174504. Available from:
  4. Bureau UC. Health Insurance Coverage in the United States: 2018. [cited 2019 Dec 16]; Available from:
  5. Ko NY, Hong S, Winn RA, Calip GS. Association of Insurance Status and Racial Disparities With the Detection of Early-Stage Breast Cancer. JAMA Oncol [Internet]. 2020 [cited 2020 Jan 22]; Available from:
  6. Morales J, Malles A, Kimble M, Rodriguez de la Vega P, Castro G, Nieder AM, et al. Does Health Insurance Modify the Association Between Race and Cancer-Specific Survival in Patients with Urinary Bladder Malignancy in the U.S.? Int J Environ Res Public Health [Internet]. 2019 [cited 2019 Oct 8];16:3393. Available from:
  7. Islami F, Sauer AG, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin [Internet]. 2017;68:31–54. Available from:
  8. Cohen AJ, Richardson CR, Heisler M, Sen A, Murphy EC, Hesterman OB, et al. Increasing Use of a Healthy Food Incentive: A Waiting Room Intervention Among Low-Income Patients. Am J Prev Med [Internet]. Elsevier; 2017;52:154–62. Available from:
  9. Tanjasiri SP, Mouttapa M, Sablan-Santos L, Weiss JW, Chavarria A, Lacsamana JD, et al. Design and Outcomes of a Community Trial to Increase Pap Testing in Pacific Islander Women. Cancer Epidemiol Biomarkers Prev [Internet]. American Association for Cancer Research; 2019 [cited 2019 Dec 16];28:1435–42. Available from:
  10. Chida Y, Hamer M, Wardle J, Steptoe A. Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pract Oncol [Internet]. 2008 [cited 2019 Dec 16];5:466–75. Available from:
  11. Hamer M, Chida Y, Molloy GJ. Psychological distress and cancer mortality. J Psychosom Res [Internet]. 2009 [cited 2019 Dec 16];66:255–8. Available from:
  12. Paskett ED, McLaughlin JM, Reiter PL, Lehman AM, Rhoda DA, Katz ML, et al. Psychosocial predictors of adherence to risk-appropriate cervical cancer screening guidelines: a cross sectional study of women in Ohio Appalachia participating in the Community Awareness Resources and Education (CARE) project. Prev Med (Baltim) [Internet]. NIH Public Access; 2010 [cited 2019 Dec 16];50:74–80. Available from:
  13. Palesh O, Butler LD, Koopman C, Giese-Davis J, Carlson R, Spiegel D. Stress history and breast cancer recurrence. J Psychosom Res [Internet]. 2007 [cited 2019 Dec 16];63:233–9. Available from:
  14. Sprehn GC, Chambers JE, Saykin AJ, Konski A, Johnstone PAS. Decreased cancer survival in individuals separated at time of diagnosis: critical period for cancer pathophysiology? Cancer [Internet]. NIH Public Access; 2009 [cited 2019 Dec 16];115:5108–16. Available from:
  15. Apenteng BA, Hansen AR, Opoku ST, Mase WA. Racial Disparities in Emotional Distress Among Cancer Survivors: Insights from the Health Information National Trends Survey (HINTS). J Cancer Educ [Internet]. Springer; 2017 [cited 2019 Dec 16];32:556–65. Available from:
  16. Linnenbringer E, Gehlert S, Geronimus AT. Black-White Disparities in Breast Cancer Subtype: The Intersection of Socially Patterned Stress and Genetic Expression. AIMS public Heal [Internet]. AIMS Press; 2017 [cited 2019 Dec 16];4:526–56. Available from:
  17. DeGuzman PB, Cohn WF, Camacho F, Edwards BL, Sturz VN, Schroen AT. Impact of Urban Neighborhood Disadvantage on Late Stage Breast Cancer Diagnosis in Virginia. J Urban Health [Internet]. Springer; 2017 [cited 2019 Dec 16];94:199. Available from:
  18. Guan A, Lichtensztajn D, Oh D, Jain J, Tao L, Hiatt RA, et al. Breast Cancer in San Francisco: Disentangling Disparities at the Neighborhood Level. Cancer Epidemiol Biomarkers Prev [Internet]. 2019 [cited 2019 Dec 16];28:1968–76. Available from:
  19. DeRouen MC, Schupp CW, Koo J, Yang J, Hertz A, Shariff-Marco S, et al. Impact of individual and neighborhood factors on disparities in prostate cancer survival. Cancer Epidemiol [Internet]. 2018 [cited 2019 Dec 16];53:1–11. Available from:
  20. Hossain F, Danos D, Prakash O, Gilliland A, Ferguson TF, Simonsen N, et al. Neighborhood Social Determinants of Triple Negative Breast Cancer. Front public Heal [Internet]. 2019 [cited 2020 Jan 22];7:18. Available from:
  21. Danos D, Leonardi C, Gilliland A, Shankar S, Srivastava RK, Simonsen N, et al. Increased Risk of Hepatocellular Carcinoma Associated With Neighborhood Concentrated Disadvantage. Front Oncol [Internet]. Frontiers Media SA; 2018 [cited 2019 Dec 16];8:375. Available from:
  22. Hardiman G, Savage SJ, Hazard ES, Wilson RC, Courtney SM, Smith MT, et al. Systems analysis of the prostate transcriptome in African–American men compared with European–American men. Pharmacogenomics [Internet]. 2016 [cited 2019 Dec 16];17:1129–43. Available from:
  23. Teslow EA, Bao B, Dyson G, Legendre C, Mitrea C, Sakr W, et al. Exogenous IL-6 induces mRNA splice variant MBD2_v2 to promote stemness in TP53 wild-type, African American PCa cells. Mol Oncol [Internet]. 2018 [cited 2019 Dec 16];12:1138–52. Available from:
  24. Wallace TA, Prueitt RL, Yi M, Howe TM, Gillespie JW, Yfantis HG, et al. Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men. Cancer Res [Internet]. 2008 [cited 2019 Dec 16];68:927–36. Available from:
  25. Robinson TJ, Freedman JA, Al Abo M, Deveaux AE, LaCroix B, Patierno BM, et al. Alternative RNA Splicing as a Potential Major Source of Untapped Molecular Targets in Precision Oncology and Cancer Disparities. Clin Cancer Res [Internet]. 2019 [cited 2019 Dec 16];25:2963–8. Available from:
  26. Jenkins BD, Martini RN, Hire R, Brown A, Bennett B, Brown I, et al. Atypical Chemokine Receptor 1 ( DARC/ACKR1 ) in Breast Tumors Is Associated with Survival, Circulating Chemokines, Tumor-Infiltrating Immune Cells, and African Ancestry. Cancer Epidemiol Biomarkers Prev [Internet]. 2019 [cited 2019 Dec 16];28:690–700. Available from:
  27. Huo D, Hu H, Rhie SK, Gamazon ER, Cherniack AD, Liu J, et al. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas. JAMA Oncol [Internet]. 2017 [cited 2019 Dec 16];3:1654. Available from:
  28. Wang S, Pitt JJ, Zheng Y, Yoshimatsu TF, Gao G, Sanni A, et al. Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria. Int J Cancer [Internet]. 2019 [cited 2019 Dec 16];145:3321–33. Available from:
  29. Rey-Vargas L, Sanabria-Salas MC, Fejerman L, Serrano-Gómez SJ. Risk Factors for Triple-Negative Breast Cancer among Latina Women. Cancer Epidemiol Biomarkers Prev [Internet]. 2019 [cited 2019 Dec 16];28:1771–83. Available from:
  30. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst [Internet]. Oxford University Press; 2011 [cited 2019 Dec 16];103:117–28. Available from:
  31. Islami F, Miller KD, Siegel RL, Zheng Z, Zhao J, Han X, et al. National and State Estimates of Lost Earnings From Cancer Deaths in the United States. JAMA Oncol [Internet]. 2019 [cited 2019 Dec 16];5:e191460. Available from:
  32. LaVeist TA, Gaskin D, Richard P. Estimating the Economic Burden of Racial Health Inequalities in the United States. Int J Heal Serv [Internet]. 2011 [cited 2019 Dec 16];41:231–8. Available from:
  33. Men’s Health Equity: A Handbook – Google Books [Internet]. [cited 2019 Dec 16]. Available from:$447.6+billion,+of+which+$24.2+billion+was+excess+medical+care+expenditures.&source=bl&ots=zAZQ0NQv71&sig=ACfU3U2ZL8xMe_He1AzrTT24ji3boSnTDA&hl=en&sa=X&ved=2ahUKEwj
  34. Susswein LR, Marshall ML, Nusbaum R, Vogel Postula KJ, Weissman SM, Yackowski L, et al. Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing. Genet Med [Internet]. 2016 [cited 2019 Jul 9];18:823–32. Available from:
  35. Huang K-L, Mashl RJ, Wu Y, Ritter DI, Wang J, Oh C, et al. Pathogenic Germline Variants in 10,389 Adult Cancers. Cell [Internet]. 2018 [cited 2019 Jul 9];173:355-370.e14. Available from:
  36. Kawanishi S, Ohnishi S, Ma N, Hiraku Y, Murata M. Crosstalk between DNA Damage and Inflammation in the Multiple Steps of Carcinogenesis. Int J Mol Sci [Internet]. 2017 [cited 2018 Jun 11];18:1808. Available from:
  37. Wojciechowska J, Krajewski W, Bolanowski M, Kręcicki T, Zatoński T. Diabetes and Cancer: a Review of Current Knowledge. Exp Clin Endocrinol Diabetes [Internet]. 2016 [cited 2019 Dec 16];124:263–75. Available from:
  38. Baselga J, Bhardwaj N, Cantley LC, DeMatteo R, DuBois RN, Foti M, et al. AACR Cancer Progress Report 2015. Clin. Cancer Res. United States; 2015. page S1-128.
  39. 1000 Genomes Project Consortium, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature [Internet]. 2015 [cited 2020 Jan 22];526:68–74. Available from:
  40. Shriver MD, Mei R, Parra EJ, Sonpar V, Halder I, Tishkoff SA, et al. Large-scale SNP analysis reveals clustered and continuous patterns of human genetic variation. Hum Genomics [Internet]. 2005 [cited 2020 Jan 22];2:81–9. Available from:
  41. Pfaff CL, Kittles RA, Shriver MD. Adjusting for population structure in admixed populations. Genet Epidemiol [Internet]. 2002 [cited 2020 Jan 22];22:196–201. Available from:
  42. Sirugo G, Williams SM, Tishkoff SA. The Missing Diversity in Human Genetic Studies. Cell [Internet]. Elsevier Inc.; 2019;177:26–31. Available from:
  43. Popejoy, Alice B., Fullerton SM. Genomics is falling. Nature. 2016;538:161–4.
  44. Han Y, Rand KA, Hazelett DJ, Ingles SA, Kittles RA, Strom SS, et al. Prostate Cancer Susceptibility in Men of African Ancestry at 8q24. J Natl Cancer Inst [Internet]. 2016 [cited 2019 Dec 16];108:djv431. Available from:
  45. Murphy AB, Ukoli F, Freeman V, Bennett F, Aiken W, Tulloch T, et al. 8q24 risk alleles in West African and Caribbean men. Prostate [Internet]. 2012 [cited 2019 Dec 16];72:1366–73. Available from:
  46. Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A, Waliszewska A, et al. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci U S A [Internet]. 2006 [cited 2020 Jan 22];103:14068–73. Available from:
  47. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, et al. A common variant associated with prostate cancer in European and African populations. Nat Genet [Internet]. 2006 [cited 2020 Jan 22];38:652–8. Available from:
  48. Han Y, Signorello LB, Strom SS, Kittles RA, Rybicki BA, Stanford JL, et al. Generalizability of established prostate cancer risk variants in men of African ancestry. Int J cancer [Internet]. 2015 [cited 2020 Jan 22];136:1210–7. Available from:
  49. Wang X, Steensma JT, Bailey MH, Feng Q, Padda H, Johnson KJ. Characteristics of The Cancer Genome Atlas cases relative to U.S. general population cancer cases. Br J Cancer [Internet]. Nature Publishing Group; 2018 [cited 2019 Dec 16];119:885–92. Available from:
  50. Spratt DE, Chan T, Waldron L, Speers C, Feng FY, Ogunwobi OO, et al. Racial/Ethnic Disparities in Genomic Sequencing. JAMA Oncol [Internet]. 2016 [cited 2019 Dec 16];2:1070. Available from:

References 101-150

  1. Dearden S, Stevens J, Wu Y-L, Blowers D. Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap). Ann Oncol Off J Eur Soc Med Oncol [Internet]. Oxford University Press; 2013 [cited 2019 Dec 16];24:2371–6. Available from:
  2. Dawson MA. Therapeutic Opportunities. 2017;1:379–85.
  3. Lahtz C, Pfeifer GP. Epigenetic changes of DNA repair genes in cancer. J Mol Cell Biol [Internet]. Oxford University Press; 2011 [cited 2019 Dec 16];3:51–8. Available from:
  4. Kanwal R, Gupta S. Epigenetic modifications in cancer. Clin Genet [Internet]. NIH Public Access; 2012 [cited 2019 Dec 16];81:303–11. Available from:
  5. Martin EM, Fry RC. Environmental Influences on the Epigenome: Exposure- Associated DNA Methylation in Human Populations. Annu Rev Public Health [Internet]. Annual Reviews ; 2018 [cited 2019 Dec 16];39:309–33. Available from:
  6. Alegría-Torres JA, Baccarelli A, Bollati V. Epigenetics and lifestyle. Epigenomics [Internet]. NIH Public Access; 2011 [cited 2019 Dec 16];3:267–77. Available from:
  7. Mcgranahan N, Swanton C. Review Clonal Heterogeneity and Tumor Evolution : Past , Present , and the Future. Cell [Internet]. Elsevier Inc.; 2017;168:613–28. Available from:
  8. Hawkins ED, Duarte D, Akinduro O, Khorshed RA, Passaro D, Nowicka M, et al. T-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments. Nature. 2016;
  9. Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med [Internet]. 2018 [cited 2019 Dec 16];24:541–50. Available from:
  10. Sun Y. Tumor microenvironment and cancer therapy resistance. Cancer Lett [Internet]. Elsevier Ireland Ltd; 2016;380:205–15. Available from:
  11. Deshmukh SK, Srivastava SK, Tyagi N, Ahmad A, Singh AP, Ghadhban AAL, et al. Emerging evidence for the role of differential tumor microenvironment in breast cancer racial disparity: a closer look at the surroundings. Carcinogenesis [Internet]. Oxford University Press; 2017 [cited 2019 Oct 31];38:757–65. Available from:
  12. Davidson NE, Armstrong SA, Coussens LM, Cruz-Correa MR, DeBerardinis RJ, Doroshow JH, et al. AACR Cancer Progress Report 2016. Clin Cancer Res. United States; 2016;22:S1–137.
  13. Kinseth MA, Jia Z, Rahmatpanah F, Sawyers A, Sutton M, Wang-Rodriguez J, et al. Expression differences between African American and Caucasian prostate cancer tissue reveals that stroma is the site of aggressive changes. Int J Cancer [Internet]. 2014 [cited 2019 Dec 16];134:81–91. Available from:
  14. Tang W, Wallace TA, Yi M, Magi-Galluzzi C, Dorsey TH, Onabajo OO, et al. IFNL4 -ΔG Allele Is Associated with an Interferon Signature in Tumors and Survival of African-American Men with Prostate Cancer. Clin Cancer Res [Internet]. 2018 [cited 2019 Dec 16];24:5471–81. Available from:
  15. AACR Cancer Progress Report 2019.
  16. Rotimi CN, Bentley AR, Doumatey AP, Chen G, Shriner D, Adeyemo A. The genomic landscape of African populations in health and disease. Hum Mol Genet [Internet]. 2017 [cited 2019 Dec 16];26:R225–36. Available from:
  17. Rotimi CN, Tekola-Ayele F, Baker JL, Shriner D. The African Diaspora: History, Adaptation and Health. Curr Opin Genet Dev [Internet]. NIH Public Access; 2016 [cited 2019 Dec 16];41:77. Available from:
  18. Schootman M, Jeffe DB, Gillanders WE, Aft R. Racial disparities in the development of breast cancer metastases among older women: a multilevel study. Cancer [Internet]. 2009 [cited 2020 Jan 22];115:731–40. Available from:
  19. Tsodikov A, Gulati R, de Carvalho TM, Heijnsdijk EAM, Hunter-Merrill RA, Mariotto AB, et al. Is prostate cancer different in black men? Answers from 3 natural history models. Cancer [Internet]. 2017 [cited 2020 Jan 22];123:2312–9. Available from:
  20. Akinyemiju T, Sakhuja S, Waterbor J, Pisu M, Altekruse SF. Racial/ethnic disparities in de novo metastases sites and survival outcomes for patients with primary breast, colorectal, and prostate cancer. Cancer Med [Internet]. 2018 [cited 2020 Jan 22];7:1183–93. Available from:
  21. Smith CJ, Minas TZ, Ambs S. Analysis of Tumor Biology to Advance Cancer Health Disparity Research. Am J Pathol [Internet]. 2018 [cited 2019 Dec 16];188:304–16. Available from:
  22. Wallace TA, Martin DN, Ambs S. Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale. Carcinogenesis [Internet]. 2011 [cited 2019 Dec 16];32:1107–21. Available from:
  23. Byun JS, Park S, Caban A, Jones A, Gardner K. Linking Race, Cancer Outcomes, and Tissue Repair. Am J Pathol [Internet]. 2018 [cited 2019 Dec 16];188:317–28. Available from:
  24. Byun JS, Gardner K. Wounds That Will Not Heal. Am J Pathol [Internet]. 2013 [cited 2019 Dec 16];182:1055–64. Available from:
  25. Gardner K. The Science of Cancer Health Disparities. Am J Pathol [Internet]. 2018 [cited 2019 Dec 16];188:268–70. Available from:
  26. Mackey LC, Annab LA, Yang J, Rao B, Kissling GE, Schurman SH, et al. Epigenetic Enzymes, Age, and Ancestry Regulate the Efficiency of Human iPSC Reprogramming. Stem Cells [Internet]. 2018 [cited 2019 Dec 16];36:1697–708. Available from:
  27. Manojlovic Z, Christofferson A, Liang WS, Aldrich J, Washington M, Wong S, et al. Comprehensive molecular profiling of 718 Multiple Myelomas reveals significant differences in mutation frequencies between African and European descent cases. Stojanov P, editor. PLoS Genet [Internet]. 2017 [cited 2020 Feb 19];13:e1007087. Available from:
  28. Chen J, Yang H, Teo ASM, Amer LB, Sherbaf FG, Tan CQ, et al. Genomic landscape of lung adenocarcinoma in East Asians. Nat Genet [Internet]. 2020 [cited 2020 Feb 19];52:177–86. Available from:
  29. Feng Y, Rhie SK, Huo D, Ruiz-Narvaez EA, Haddad SA, Ambrosone CB, et al. Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry. Cancer Epidemiol Biomarkers Prev [Internet]. American Association for Cancer Research; 2017 [cited 2020 Feb 19];26:1016–26. Available from:
  30. Fejerman L, Ahmadiyeh N, Hu D, Huntsman S, Beckman KB, Caswell JL, et al. Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25. Nat Commun [Internet]. Nature Publishing Group; 2014 [cited 2020 Feb 19];5:5260. Available from:
  31. Huang FW, Mosquera JM, Garofalo A, Oh C, Baco M, Amin-Mansour A, et al. Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations. Cancer Discov [Internet]. 2017 [cited 2020 Feb 19];7:973–83. Available from:
  32. Creamer MLR, Wang TW, Babb S, Cullen KA, Day H, Willis G, et al. Tobacco Product Use and Cessation Indicators Among Adults – United States, 2018. MMWR Morb Mortal Wkly Rep. 2019;68:1013–9.
  33. Goding Sauer A, Siegel RL, Jemal A, Fedewa SA. Current Prevalence of Major Cancer Risk Factors and Screening Test Use in the United States: Disparities by Education and Race/Ethnicity. Cancer Epidemiol Biomarkers Prev [Internet]. 2019;28:629–42. Available from:
  34. Gallaway MS, Henley SJ, Steele CB, Momin B, Thomas CC, Jamal A, et al. Surveillance for Cancers Associated with Tobacco Use — United States, 2010–2014. MMWR Surveill Summ [Internet]. 2018;67:1–42. Available from:
  35. Lundeen EA, Park S, Pan L, O’Toole T, Matthews K, Blanck HM. Obesity Prevalence Among Adults Living in Metropolitan and Nonmetropolitan Counties – United States, 2016. MMWR Morb Mortal Wkly Rep [Internet]. 2018 [cited 2019 Jun 19];67:653–8. Available from:
  36. Adult Physical Inactivity Prevalence Maps by Race/Ethnicity | Physical Activity | CDC [Internet]. [cited 2020 Jan 17]. Available from:
  37. CDC Vital Signs, November 2016. Cancer and tobacco use. CDC Vital Signs, November, 2016.
  38. Barrow TM, Klett H, Toth R, Böhm J, Gigic B, Habermann N, et al. Smoking is associated with hypermethylation of the APC 1A promoter in colorectal cancer: the ColoCare Study. J Pathol [Internet]. 2017 [cited 2018 Mar 15];243:366–75. Available from:
  39. United States Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress A Report of the Surgeon General. A Rep Surg Gen. 2014;1081.
  40. Tsai J, Homa DM, Gentzke AS, Mahoney M, Sharapova SR, Sosnoff CS, et al. Exposure to Secondhand Smoke Among Nonsmokers — United States, 1988–2014. MMWR Morb Mortal Wkly Rep [Internet]. 2018;67:1342–6. Available from:
  41. Arrazola RA, Dube SR, King BA. Tobacco product use among middle and high school students – United States, 2011 and 2012. Morb Mortal Wkly Rep. 2013;62:893–7.
  42. Schoenborn CA, Adams PF, Peregoy JA. Health behaviors of adults: United States, 2008-2010. Vital Health Stat 10 [Internet]. 2013 [cited 2019 Dec 16];1–184. Available from:
  43. Lawrence D, Rose A, Fagan P, Moolchan ET, Gibson JT, Backinger CL. National patterns and correlates of mentholated cigarette use in the United States. Addiction [Internet]. 2010 [cited 2019 Dec 16];105:13–31. Available from:
  44. Villanti AC, Collins LK, Niaura RS, Gagosian SY, Abrams DB. Menthol cigarettes and the public health standard: a systematic review. BMC Public Health [Internet]. 2017 [cited 2020 Jan 23];17:983. Available from:
  45. American Cancer Society. Cancer Facts & Figures for African Americans 2019-2021. Atlanta: American Cancer Society, 2019. 2019;
  46. Babb S, Malarcher A, Schauer G, Asman K, Jamal A. Quitting Smoking Among Adults — United States, 2000–2015. MMWR Morb Mortal Wkly Rep [Internet]. 2017 [cited 2019 Dec 16];65:1457–64. Available from:
  47. Centers for Disease Control and Prevention. Best Practices User Guide: Health Equity in Tobacco Prevention and Control. 2015;1–52. Available from:
  48. Tibuakuu M, Okunrintemi V, Jirru E, Echouffo Tcheugui JB, Orimoloye OA, Mehta PK, et al. National Trends in Cessation Counseling, Prescription Medication Use, and Associated Costs Among US Adult Cigarette Smokers. JAMA Netw Open [Internet]. American Medical Association; 2019 [cited 2019 Dec 16];2:e194585. Available from:
  49. Stratton K, Kwan LY, Eaton DL, Effects H, Delivery N, Health P, et al. Public Health Consequences of E-Cigarettes [Internet]. National Academies Press; 2018. Available from:
  50. Lauby‑secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K. Body Fatness and Cancer — Viewpoint of the IARC Working Group. 2016;8.

References 151-200

  1. Body fatness and weight gain and the risk of cancer. World Cancer Res Fund/American Inst Cancer Res Contin Updat Proj Expert Rep 2018 Body fatness Weight gain risk cancer Available from:
  2. Cao Y, Ma J. Body Mass Index, Prostate Cancer-Specific Mortality, and Biochemical Recurrence: a Systematic Review and Meta-analysis. Cancer Prev Res [Internet]. 2011 [cited 2019 Dec 16];4:486–501. Available from:
  3. Campbell PT, Newton CC, Dehal AN, Jacobs EJ, Patel A V., Gapstur SM. Impact of Body Mass Index on Survival After Colorectal Cancer Diagnosis: The Cancer Prevention Study-II Nutrition Cohort. J Clin Oncol [Internet]. 2012 [cited 2019 Dec 16];30:42–52. Available from:
  4. Harrison R. The State of Obesity: 2019. 1905;10:1055. Available from:
  5. Freedman DS, Khan LK, Serdula MK, Dietz WH, Srinivasan SR, Berenson GS. Racial Differences in the Tracking of Childhood BMI to Adulthood. Obes Res [Internet]. 2005 [cited 2019 Dec 16];13:928–35. Available from:
  6. Barrington WE, Schenk JM, Etzioni R, Arnold KB, Neuhouser ML, Thompson IM, et al. Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA Oncol [Internet]. 2015 [cited 2019 Dec 16];1:342. Available from:
  7. Zhang FF, Cudhea F, Shan Z, Michaud DS, Imamura F, Eom H, et al. Preventable Cancer Burden Associated with Poor Diet in the United States. JNCI Cancer Spectr [Internet]. 2019 [cited 2019 Jun 19]; Available from:
  8. Afshin A, Sur PJ, Fay KA, Cornaby L, Ferrara G, Salama JS, et al. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet [Internet]. 2019;6736. Available from:
  9. Wang Y, Chen X. How much of racial/ethnic disparities in dietary intakes, exercise, and weight status can be explained by nutrition- and health-related psychosocial factors and socioeconomic status among US adults? J Am Diet Assoc [Internet]. 2011 [cited 2019 Dec 16];111:1904–11. Available from:
  10. Hiza HAB, Casavale KO, Guenther PM, Davis CA. Diet quality of Americans differs by age, sex, race/ethnicity, income, and education level. J Acad Nutr Diet [Internet]. 2013 [cited 2019 Dec 16];113:297–306. Available from:
  11. Richards Adams IK, Figueroa W, Hatsu I, Odei JB, Sotos-Prieto M, Leson S, et al. An Examination of Demographic and Psychosocial Factors, Barriers to Healthy Eating, and Diet Quality Among African American Adults. Nutrients [Internet]. 2019 [cited 2019 Dec 16];11:519. Available from:
  12. Siega-Riz AM, Pace ND, Butera NM, Van Horn L, Daviglus ML, Harnack L, et al. How Well Do U.S. Hispanics Adhere to the Dietary Guidelines for Americans? Results from the Hispanic Community Health Study/Study of Latinos. Heal equity [Internet]. 2019 [cited 2019 Dec 16];3:319–27. Available from:
  13. Patetta MA, Pedraza LS, Popkin BM. Improvements in the nutritional quality of US young adults based on food sources and socioeconomic status between 1989-1991 and 2011-2014. Nutr J [Internet]. 2019 [cited 2019 Dec 16];18:32. Available from:
  14. Hoy MK, Sebastian RS, Goldman JD, Wilkinson Enns C, Moshfegh AJ. Consuming Vegetable-Based Salad Is Associated with Higher Nutrient Intakes and Diet Quality among US Adults, What We Eat in America, National Health and Nutrition Examination Survey 2011-2014. J Acad Nutr Diet [Internet]. 2019 [cited 2019 Dec 16];119:2085–92. Available from:
  15. Rosiner A, Herrick K, Gahche JJ, Park S. Sugar-sweetened Beverage Consumption Among U.S. Youth, 2011–2014. NCHS Data Brief [Internet]. 2017;1–7. Available from:
  16. Rosiner A, Herrick K, Gahche JJ, Park S, Kumar G, Pan L, et al. Sugar-sweetened beverage consumption among adults-18 States, 2012. Morb Mortal Wkly Rep [Internet]. 2014;63:686–90. Available from:
  17. America HF. Introduction HEALTHY FOOD AMERICA | Report Sugary Drinks in America: Who’s Drinking What and How Much? 2018;1–23. Available from:
  18. American Cancer Society. Cancer Prevention & Early Detection Facts & Figures 2017-2018.
  19. Lee MM, Falbe J, Schillinger D, Basu S, McCulloch CE, Madsen KA. Sugar-Sweetened Beverage Consumption 3 Years After the Berkeley, California, Sugar-Sweetened Beverage Tax. Am J Public Health. 2019;109:637–9.
  20. Roberto CA, Lawman HG, Levasseur MT, Mitra N, Peterhans A, Herring B, et al. Association of a Beverage Tax on Sugar-Sweetened and Artificially Sweetened Beverages with Changes in Beverage Prices and Sales at Chain Retailers in a Large Urban Setting. JAMA – J Am Med Assoc. 2019;321:1799–810.
  21. Christopher GC, Harris CM, Harris RT, Gibson SM, Mcguire CK, Sanchez E, et al. The State of Obesity 2017. Trust Am Heal [Internet]. 2017; Available from:
  22. Bower KM, Thorpe RJ, Rohde C, Gaskin DJ. No Title. 2014 [cited 2019 Oct 16];58. Available from:
  23. Byrd DA, Agurs-Collins T, Berrigan D, Lee R, Thompson FE. Racial and Ethnic Differences in Dietary Intake, Physical Activity, and Body Mass Index (BMI) Among Cancer Survivors: 2005 and 2010 National Health Interview Surveys (NHIS). J Racial Ethn Heal Disparities [Internet]. 2017 [cited 2019 Mar 6];4:1138–46. Available from:
  24. Springfield S, Odoms-Young A, Tussing-Humphreys L, Freels S, Stolley M. Adherence to American Cancer Society and American Institute of Cancer Research dietary guidelines in overweight African American breast cancer survivors. J Cancer Surviv [Internet]. 2019 [cited 2019 Dec 16];13:257–68. Available from:
  25. Kane K, Ilic S, Paden H, Lustberg M, Grenade C, Bhatt A, et al. An Evaluation of Factors Predicting Diet Quality among Cancer Patients. Nutrients [Internet]. 2018 [cited 2019 Dec 16];10:1019. Available from:
  26. World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Expert Report 2018. Physical activity and the risk of cancer. Available at
  27. Marshall CH, Al‐Mallah MH, Dardari Z, Brawner CA, Lamerato LE, Keteyian SJ, et al. Cardiorespiratory fitness and incident lung and colorectal cancer in men and women: Results from the Henry Ford Exercise Testing (FIT) cohort. Cancer [Internet]. 2019 [cited 2019 Jun 19];cncr.32085. Available from:
  28. Matthews CE, Moore SC, Arem H, Cook MB, Trabert B, Håkansson N, et al. Amount and Intensity of Leisure-Time Physical Activity and Lower Cancer Risk. J Clin Oncol. 2019;JCO.19.02407.
  29. McTiernan A, Friedenreich CM, Katzmarzyk PT, Powell KE, Macko R, Buchner D, et al. Physical Activity in Cancer Prevention and Survival. Med Sci Sport Exerc [Internet]. 2019 [cited 2019 Jun 20];51:1252–61. Available from:
  30. Ussery EN, Fulton JE, Galuska DA, Katzmarzyk PT, Carlson SA. Joint Prevalence of Sitting Time and Leisure-Time Physical Activity Among US Adults, 2015-2016. JAMA [Internet]. American Medical Association; 2018 [cited 2019 Jun 19];320:2036. Available from:
  31. National Physical Activity Plan Alliance. The 2018 United States Report Card on Physical Activity for Children and Youth. Washington, DC: National Physical Activity Plan Alliance, 2018. 2001;8:33–42.
  32. Du Y, Liu B, Sun Y, Snetselaar LG, Wallace RB, Bao W. Trends in Adherence to the Physical Activity Guidelines for Americans for Aerobic Activity and Time Spent on Sedentary Behavior Among US Adults, 2007 to 2016. JAMA Netw Open [Internet]. 2019;2:e197597. Available from:
  33. Crespo CJ, Smit E, Andersen RE, Carter-Pokras O, Ainsworth BE. Race/ethnicity, social class and their relation to physical inactivity during leisure time: results from the Third National Health and Nutrition Examination Survey, 1988–1994. Am J Prev Med [Internet]. 2000 [cited 2019 Dec 16];18:46–53. Available from:
  34. CDC WONDER DATA2010 – Home Page [Internet]. [cited 2019 Dec 16]. Available from:
  35. Piercy KL, Troiano RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA, et al. The Physical Activity Guidelines for Americans. JAMA [Internet]. American Medical Association; 2018 [cited 2019 Jun 19];320:2020. Available from:
  36. Cheng CE, Irwin B, Mauriello D, Hemminger L, Pappert A, Kimball AB. Health Disparities Among Different Ethnic and Racial Middle and High School Students in Sun Exposure Beliefs and Knowledge. J Adolesc Heal [Internet]. 2010 [cited 2019 Dec 16];47:106–9. Available from:
  37. Summers P, Bena J, Arrigain S, Alexis AF, Cooper K, Bordeaux JS. Sunscreen use: Non-Hispanic Blacks compared with other racial and/or ethnic groups. Arch Dermatol [Internet]. 2011 [cited 2019 Dec 16];147:863–4. Available from:
  38. Correnti CM, Klein DJ, Elliott MN, Veledar E, Saraiya M, Chien AT, et al. Racial disparities in fifth-grade sun protection: Evidence from the Healthy Passages study. Pediatr Dermatol [Internet]. 2018 [cited 2019 Jul 7];35:588–96. Available from:
  39. Dennis LK, Vanbeek MJ, Beane Freeman LE, Smith BJ, Dawson D V, Coughlin JA. Sunburns and risk of cutaneous melanoma: does age matter? A comprehensive meta-analysis. Ann Epidemiol [Internet]. NIH Public Access; 2008 [cited 2019 Jul 10];18:614–27. Available from:
  40. Buster KJ, You Z, Fouad M, Elmets C. Skin cancer risk perceptions: a comparison across ethnicity, age, education, gender, and income. J Am Acad Dermatol [Internet]. 2012 [cited 2019 Dec 16];66:771–9. Available from:
  41. Bradford PT. Skin cancer in skin of color. Dermatology Nurs [Internet]. [cited 2019 Jun 19];21:170–7, 206; quiz 178. Available from:
  42. Gloster HM, Neal K. Skin cancer in skin of color. J Am Acad Dermatol [Internet]. 2006 [cited 2019 Jun 19];55:741–60; quiz 761–4. Available from:
  43. Kasting ML, Giuliano AR, Reich RR, Roetzheim RG, Duong LM, Thomas E, et al. Hepatitis C virus screening trends: A 2016 update of the National Health Interview Survey. Cancer Epidemiol [Internet]. Elsevier; 2019 [cited 2019 May 14];60:112–20. Available from:
  44. Forde KA. Ethnic Disparities in Chronic Hepatitis B Infection: African Americans and Hispanic Americans. Curr Hepatol Reports [Internet]. 2017 [cited 2019 Dec 16];16:105–12. Available from:
  45. Ryerson AB, Eheman CR, Altekruse SF, Ward JW, Jemal A, Sherman RL, et al. Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer. Cancer [Internet]. John Wiley & Sons, Ltd; 2016 [cited 2019 Jun 19];122:1312–37. Available from:
  46. Oakes MH. Viral Hepatitis Surveillance United States, 2016. J Maine Med Assoc. 2016;52:222–3.
  47. Luo G, Zhang Y, Guo P, Wang L, Huang Y, Li K. Global patterns and trends in stomach cancer incidence: Age, period and birth cohort analysis. Int J Cancer [Internet]. 2017 [cited 2019 Dec 17];141:1333–44. Available from:
  48. HPV Vaccination for Cancer Prevention: Progress, Opportunities, and a Renewed Call to Action. A Report to the President of the United States from the Chair of the President’s Cancer Panel. Bethesda (MD): President’s Cancer Panel; 2018 Nov. 1971;281. Available from:
  49. Mcquillan G, Kruszon-moran D, Markowitz LE, Unger ER, Paulose-ram R. Prevalence of HPV in Adults Aged 18 – 69 : United States, 2011-2014. NCHS Data Brief [Internet]. 2017;2011–4. Available from:
  50. Van Dyne EA, Henley SJ, Saraiya M, Thomas CC, Markowitz LE, Benard VB. Trends in Human Papillomavirus–Associated Cancers — United States, 1999–2015. MMWR Morb Mortal Wkly Rep [Internet]. 2018;67:918–24. Available from:

References 201-250

  1. Hirth J. Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature. Hum Vaccin Immunother [Internet]. 2019 [cited 2019 Dec 17];15:146–55. Available from:
  2. Gelman A, Miller E, Schwarz EB, Akers AY, Jeong K, Borrero S. Racial disparities in human papillomavirus vaccination: does access matter? J Adolesc Health [Internet]. 2013 [cited 2019 Dec 17];53:756–62. Available from:
  3. Vick AD, Burris HH. Epigenetics and Health Disparities. Curr Epidemiol reports [Internet]. 2017 [cited 2019 Dec 17];4:31–7. Available from:
  4. Xing CY, Doose M, Qin B, Lin Y, Plascak JJ, Omene C, et al. Prediagnostic Allostatic Load as a Predictor of Poorly Differentiated and Larger Sized Breast Cancers among Black Women in the Women’s Circle of Health Follow-Up Study. Cancer Epidemiol Biomarkers Prev [Internet]. 2020 [cited 2020 Jan 22];29:216–24. Available from:
  5. Shiels PG, Buchanan S, Selman C, Stenvinkel P. Allostatic load and ageing: linking the microbiome and nutrition with age-related health. Biochem Soc Trans [Internet]. 2019 [cited 2020 Jan 22];47:1165–72. Available from:
  6. Cacioppo JT, Hawkley LC. Social isolation and health, with an emphasis on underlying mechanisms. Perspect Biol Med [Internet]. 2003 [cited 2019 Dec 17];46:S39-52. Available from:
  7. Williams DR, Collins C. Racial residential segregation: a fundamental cause of racial disparities in health. Public Health Rep [Internet]. 2001 [cited 2019 Dec 17];116:404–16. Available from:
  8. McClintock MK, Conzen SD, Gehlert S, Masi C, Olopade F. Mammary Cancer and Social Interactions: Identifying Multiple Environments That Regulate Gene Expression Throughout the Life Span. Journals Gerontol Ser B [Internet]. 2005 [cited 2019 Dec 17];60:32–41. Available from:
  9. Cuevas AG, Trudel-Fitzgerald C, Cofie L, Zaitsu M, Allen J, Williams DR. Placing prostate cancer disparities within a psychosocial context: challenges and opportunities for future research. Cancer Causes Control [Internet]. 2019 [cited 2019 Dec 17];30:443–56. Available from:
  10. Loomis D, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, et al. The carcinogenicity of outdoor air pollution. Lancet Oncol [Internet]. 2013 [cited 2019 Jun 19];14:1262–3. Available from:
  11. Tessum CW, Apte JS, Goodkind AL, Muller NZ, Mullins KA, Paolella DA, et al. Inequity in consumption of goods and services adds to racial-ethnic disparities in air pollution exposure. Proc Natl Acad Sci U S A [Internet]. 2019 [cited 2019 Dec 17];116:6001–6. Available from:
  12. Cushing L, Faust J, August LM, Cendak R, Wieland W, Alexeeff G. Racial/Ethnic Disparities in Cumulative Environmental Health Impacts in California: Evidence From a Statewide Environmental Justice Screening Tool (CalEnviroScreen 1.1). Am J Public Health [Internet]. 2015 [cited 2019 Dec 17];105:2341–8. Available from:
  13. Weichenthal S, Moase C, Chan P. A review of pesticide exposure and cancer incidence in the Agricultural Health Study cohort. Environ Health Perspect [Internet]. 2010 [cited 2019 Dec 17];118:1117–25. Available from:
  14. Alavanja MCR, Bonner MR. Occupational pesticide exposures and cancer risk: a review. J Toxicol Environ Health B Crit Rev [Internet]. 2012 [cited 2019 Dec 17];15:238–63. Available from:
  15. Diamanti-Kandarakis E, Bourguignon J-P, Giudice LC, Hauser R, Prins GS, Soto AM, et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev [Internet]. 2009 [cited 2019 Dec 17];30:293–342. Available from:
  16. Attina TM, Malits J, Naidu M, Trasande L. Racial/ethnic disparities in disease burden and costs related to exposure to endocrine-disrupting chemicals in the United States: an exploratory analysis. J Clin Epidemiol [Internet]. 2019 [cited 2019 Dec 17];108:34–43. Available from:
  17. IARC Monographs Vol 124 group EM, Germolec D, Kogevinas M, McCormick D, Vermeulen R, Anisimov VN, et al. Carcinogenicity of night shift work. Lancet Oncol [Internet]. 2019 [cited 2019 Dec 17];20:1058–9. Available from:
  18. Jackson CL, Redline S, Kawachi I, Williams MA, Hu FB. Racial disparities in short sleep duration by occupation and industry. Am J Epidemiol [Internet]. 2013 [cited 2019 Dec 17];178:1442–51. Available from:
  19. Grandner MA, Williams NJ, Knutson KL, Roberts D, Jean-Louis G. Sleep disparity, race/ethnicity, and socioeconomic position. Sleep Med [Internet]. 2016 [cited 2019 Dec 17];18:7–18. Available from:
  20. Jemal A, Fedewa SA, E B. Lung Cancer Screening With Low-Dose Computed Tomography in the United States—2010 to 2015. JAMA Oncol [Internet]. 2017 [cited 2017 Feb 3];63:107–17. Available from:
  21. Warnecke RB, Campbell RT, Vijayasiri G, Barrett RE, Rauscher GH. Multilevel Examination of Health Disparity: The Role of Policy Implementation in Neighborhood Context, in Patient Resources, and in Healthcare Facilities on Later Stage of Breast Cancer Diagnosis. Cancer Epidemiol Biomarkers Prev [Internet]. 2019 [cited 2019 Dec 17];28:59–66. Available from:
  22. Mann L, Foley KL, Tanner AE, Sun CJ, Rhodes SD. Increasing Cervical Cancer Screening Among US Hispanics/Latinas: A Qualitative Systematic Review. J Cancer Educ [Internet]. NIH Public Access; 2015 [cited 2019 Dec 17];30:374–87. Available from:
  23. American Cancer Society Cancer Action Network. Cancer Disparities: A Chartbook. Strategies [Internet]. 2018; Available from:
  24. Rex DK, Boland RC, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, et al. Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol [Internet]. 2017 [cited 2019 Dec 17];112:1016–30. Available from:
  26. O’Neil ME, Henley SJ, Singh SD, Wilson RJ, Ortiz-Ortiz KJ, Ríos NP, et al. Invasive cancer incidence – Puerto Rico, 2007-2011. MMWR Morb Mortal Wkly Rep [Internet]. 2015 [cited 2019 Dec 18];64:389–93. Available from:
  27. American Cancer Society. Colorectal Cancer Facts & Figures 2017-2019. Atlanta: American Cancer Society; 2017. 2019;
  28. May FP, Whitman CB, Varlyguina K, Bromley EG, Spiegel BMR. Addressing Low Colorectal Cancer Screening in African Americans: Using Focus Groups to Inform the Development of Effective Interventions. J Cancer Educ [Internet]. 2016 [cited 2019 Dec 17];31:567–74. Available from:
  29. Bromley EG, May FP, Federer L, Spiegel BMR, van Oijen MGH. Explaining persistent under-use of colonoscopic cancer screening in African Americans: a systematic review. Prev Med (Baltim) [Internet]. NIH Public Access; 2015 [cited 2019 Dec 17];71:40–8. Available from:
  30. Hong Y-R, Tauscher J, Cardel M. Distrust in health care and cultural factors are associated with uptake of colorectal cancer screening in Hispanic and Asian Americans. Cancer [Internet]. John Wiley & Sons, Ltd; 2018 [cited 2019 Dec 17];124:335–45. Available from:
  31. Emmons K, Puleo E, McNeill LH, Bennett G, Chan S, Syngal S. Colorectal cancer screening awareness and intentions among low income, sociodemographically diverse adults under age 50. Cancer Causes Control [Internet]. NIH Public Access; 2008 [cited 2019 Dec 17];19:1031–41. Available from:
  32. American Lung Association. State of Lung Cancer. 2018; Available from:
  33. Huo J, Hong Y-R, Bian J, Guo Y, Wilkie DJ, Mainous AG. Low Rates of Patient-Reported Physician–Patient Discussion about Lung Cancer Screening among Current Smokers: Data from Health Information National Trends Survey. Cancer Epidemiol Biomarkers Prev [Internet]. American Association for Cancer Research; 2019 [cited 2019 Jun 20];28:963–73. Available from:
  34. Haiman CA, Stram DO, Wilkens LR, Pike MC, Kolonel LN, Henderson BE, et al. Ethnic and Racial Differences in the Smoking-Related Risk of Lung Cancer. N Engl J Med [Internet]. Massachusetts Medical Society ; 2006 [cited 2019 Dec 17];354:333–42. Available from:
  35. Tanner NT, Gebregziabher M, Hughes Halbert C, Payne E, Egede LE, Silvestri GA. Racial Differences in Outcomes within the National Lung Screening Trial. Implications for Widespread Implementation. Am J Respir Crit Care Med [Internet]. 2015 [cited 2020 Jan 22];192:200–8. Available from:
  36. Pasquinelli MM, Kovitz KL, Koshy M, Menchaca MG, Liu L, Winn R, et al. Outcomes From a Minority-Based Lung Cancer Screening Program vs the National Lung Screening Trial. JAMA Oncol [Internet]. American Medical Association; 2018 [cited 2019 Dec 17];4:1291. Available from:
  37. Team TNLSTR. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. N Engl J Med [Internet]. Massachusetts Medical Society; 2011 [cited 2019 Dec 17];365:395–409. Available from:
  38. Cooper DL, Rollins L, Slocumb T, Rivers BM. Are Men Making Informed Decisions According to the Prostate-Specific Antigen Test Guidelines? Analysis of the 2015 Behavioral Risk Factor Surveillance System. Am J Mens Health [Internet]. SAGE Publications; 2019 [cited 2019 Dec 17];13:1557988319834843. Available from:
  39. Miller EA, Pinsky PF, Black A, Andriole GL, Pierre-Victor D. Secondary prostate cancer screening outcomes by race in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial. Prostate [Internet]. 2018 [cited 2019 Dec 17];78:830–8. Available from:
  40. Vang S, Margolies LR, Jandorf L. Mobile Mammography Participation Among Medically Underserved Women: A Systematic Review. Prev Chronic Dis [Internet]. 2018 [cited 2019 Dec 17];15:180291. Available from:
  41. Stanley E, Lewis MC, Irshad A, Ackerman S, Collins H, Pavic D, et al. Effectiveness of a Mobile Mammography Program. Am J Roentgenol [Internet]. 2017 [cited 2019 Dec 17];209:1426–9. Available from:
  42. Rice K, Gressard L, DeGroff A, Gersten J, Robie J, Leadbetter S, et al. Increasing colonoscopy screening in disparate populations: Results from an evaluation of patient navigation in the New Hampshire Colorectal Cancer Screening Program. Cancer [Internet]. NIH Public Access; 2017 [cited 2019 Dec 17];123:3356–66. Available from:
  43. Dougherty MK, Brenner AT, Crockett SD, Gupta S, Wheeler SB, Coker-Schwimmer M, et al. Evaluation of Interventions Intended to Increase Colorectal Cancer Screening Rates in the United States: A Systematic Review and Meta-analysis. JAMA Intern Med [Internet]. American Medical Association; 2018 [cited 2019 Dec 17];178:1645–58. Available from:
  44. Christy SM, Davis SN, Williams KR, Zhao X, Govindaraju SK, Quinn GP, et al. A community-based trial of educational interventions with fecal immunochemical tests for colorectal cancer screening uptake among blacks in community settings. Cancer [Internet]. NIH Public Access; 2016 [cited 2019 Dec 17];122:3288–96. Available from:
  45. Goldman SN, Liss DT, Brown T, Lee JY, Buchanan DR, Balsley K, et al. Comparative Effectiveness of Multifaceted Outreach to Initiate Colorectal Cancer Screening in Community Health Centers: A Randomized Controlled Trial. J Gen Intern Med [Internet]. Springer; 2015 [cited 2019 Dec 17];30:1178–84. Available from:
  46. Grubbs SS, Polite BN, Carney J, Jr, Bowser W, Rogers J, et al. Eliminating Racial Disparities in Colorectal Cancer in the Real World: It Took a Village. J Clin Oncol [Internet]. American Society of Clinical Oncology; 2013 [cited 2019 Dec 17];31:1928. Available from:
  47. Ochoa CY, Murphy ST, Frank LB, Baezconde-Garbanati LA. Using a Culturally Tailored Narrative to Increase Cervical Cancer Detection Among Spanish-Speaking Mexican-American Women. J Cancer Educ [Internet]. J Cancer Educ; 2019 [cited 2020 Jan 22]; Available from:
  48. Thompson B, Carosso EA, Jhingan E, Wang L, Holte SE, Byrd TL, et al. Results of a randomized controlled trial to increase cervical cancer screening among rural Latinas. Cancer [Internet]. 2017 [cited 2020 Jan 22];123:666–74. Available from:
  49. Ma GX, Fang C, Tan Y, Feng Z, Ge S, Nguyen C. Increasing Cervical Cancer Screening Among Vietnamese Americans: A Community-Based Intervention Trial. J Health Care Poor Underserved [Internet]. 2015 [cited 2020 Jan 22];26:36–52. Available from:
  50. Benard VB, Lawson HW, Eheman CR, Anderson C, Helsel W. Adherence to Guidelines for Follow-up of Low-Grade Cytologic Abnormalities Among Medically Underserved Women. Obstet Gynecol [Internet]. 2005 [cited 2020 Jan 22];105:1323–8. Available from:

References 251-300

  1. Engelstad LP, Stewart SL, Nguyen BH, Bedeian KL, Rubin MM, Pasick RJ, et al. Abnormal Pap smear follow-up in a high-risk population. Cancer Epidemiol Biomarkers Prev [Internet]. American Association for Cancer Research; 2001 [cited 2020 Jan 22];10:1015–20. Available from:
  2. Chase DM, Osann K, Sepina N, Wenzel L, Tewari KS. The Challenge of Follow-Up in a Low-Income Colposcopy Clinic. J Low Genit Tract Dis [Internet]. 2012 [cited 2020 Jan 22];16:345–51. Available from:
  3. Penner LA, Blair I V, Albrecht TL, Dovidio JF. Reducing Racial Health Care Disparities: A Social Psychological Analysis. Policy insights from Behav brain Sci [Internet]. NIH Public Access; 2014 [cited 2019 Dec 17];1:204–12. Available from:
  4. Zhang S, Liu Y, Yun S, Lian M, Komaie G, Colditz GA. Impacts of Neighborhood Characteristics on Treatment and Outcomes in Women with Ductal Carcinoma In Situ of the Breast. Cancer Epidemiol Biomarkers Prev [Internet]. American Association for Cancer Research; 2018 [cited 2019 Jun 20];27:1298–306. Available from:
  5. Jain V, Venigalla S, Sebro RA, Karakousis GC, Wilson RJ, Weber KL, et al. Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma. Cancer Med [Internet]. 2019 [cited 2020 Jan 22];8:6295–304. Available from:
  6. Klapheke A, Yap SA, Pan K, Cress RD. Sociodemographic disparities in chemotherapy treatment and impact on survival among patients with metastatic bladder cancer. Urol Oncol. United States; 2018;36:308.e19-308.e25.
  7. Duma N, Vera Aguilera J, Paludo J, Haddox CL, Gonzalez Velez M, Wang Y, et al. Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years. J Oncol Pract [Internet]. 2017;14:JOP.2017.025288. Available from:
  8. Nazha B, Mishra M, Pentz R, Owonikoko TK. Enrollment of Racial Minorities in Clinical Trials: Old Problem Assumes New Urgency in the Age of Immunotherapy. Am Soc Clin Oncol Educ book Am Soc Clin Oncol Annu Meet [Internet]. American Society of Clinical OncologyAlexandria, VA; 2019 [cited 2019 Dec 17];39:3–10. Available from:
  9. Fillmore NR, Yellapragada S V, Ifeorah C, Mehta A, Cirstea D, White PS, et al. With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study. Blood [Internet]. 2019 [cited 2019 Jun 20];133:2615–8. Available from:
  10. Williams CD, Salama JK, Moghanaki D, Karas TZ, Kelley MJ. Impact of Race on Treatment and Survival among U.S. Veterans with Early-Stage Lung Cancer. J Thorac Oncol [Internet]. Elsevier; 2016 [cited 2019 Dec 17];11:1672–81. Available from:
  11. Riviere P, Luterstein E, Kumar A, Vitzthum LK, Deka R, Sarkar RR, et al. Survival of African American and non‐Hispanic white men with prostate cancer in an equal‐access health care system. Cancer [Internet]. John Wiley & Sons, Ltd; 2020 [cited 2020 Jan 27];cncr.32666. Available from:
  12. Molina Y, Silva A, Rauscher GH. Racial/Ethnic Disparities in Time to a Breast Cancer Diagnosis: The Mediating Effects of Health Care Facility Factors. Med Care [Internet]. NIH Public Access; 2015 [cited 2019 Dec 17];53:872–8. Available from:
  13. George P, Chandwani S, Gabel M, Ambrosone CB, Rhoads G, Bandera E V, et al. Diagnosis and surgical delays in African American and white women with early-stage breast cancer. J Womens Health (Larchmt) [Internet]. Mary Ann Liebert, Inc.; 2015 [cited 2019 Dec 17];24:209–17. Available from:
  14. Keating NL, Kouri EM, He Y, Freedman RA, Volya R, Zaslavsky AM. Location Isn’t Everything: Proximity, Hospital Characteristics, Choice of Hospital, and Disparities for Breast Cancer Surgery Patients. Health Serv Res [Internet]. John Wiley & Sons, Ltd (10.1111); 2016 [cited 2019 Dec 17];51:1561–83. Available from:
  15. Penner LA, Dovidio JF, Gonzalez R, Albrecht TL, Chapman R, Foster T, et al. The Effects of Oncologist Implicit Racial Bias in Racially Discordant Oncology Interactions. J Clin Oncol [Internet]. 2016 [cited 2020 Jan 22];34:2874–80. Available from:
  16. Liang J, Wolsiefer K, Zestcott CA, Chase D, Stone J. Implicit bias toward cervical cancer: Provider and training differences. Gynecol Oncol [Internet]. 2019 [cited 2020 Jan 22];153:80–6. Available from:
  17. Soni SE, Lee MC, Gwede CK. Disparities in Use and Access to Postmastectomy Breast Reconstruction Among African American Women: A Targeted Review of the Literature. Cancer Control [Internet]. SAGE Publications; 2017 [cited 2019 Dec 17];24:1073274817729053. Available from:
  18. Paquette IM, Kemp JA, Finlayson SRG. Patient and Hospital Factors Associated With Use of Sphincter-Sparing Surgery for Rectal Cancer. Dis Colon Rectum [Internet]. 2010 [cited 2019 Dec 17];53:115–20. Available from:
  19. Markt SC, Tang T, Cronin AM, Katz IT, Howitt BE, Horowitz NS, et al. Insurance status and cancer treatment mediate the association between race/ethnicity and cervical cancer survival. PLoS One [Internet]. Public Library of Science; 2018 [cited 2019 Dec 17];13:e0193047. Available from:
  20. Toubat O, Farias AJ, Atay SM, McFadden PM, Kim AW, David EA. Disparities in the surgical management of early stage non-small cell lung cancer: how far have we come? J Thorac Dis [Internet]. AME Publications; 2019 [cited 2019 Dec 17];11:S596–611. Available from:
  21. Robinson CN, Balentine CJ, Marshall CL, Anaya DA, Artinyan A, Awad SA, et al. Ethnic disparities are reduced in VA colon cancer patients. Am J Surg [Internet]. 2010 [cited 2019 Dec 17];200:636–9. Available from:
  22. Esnaola NF, Ford ME. Racial differences and disparities in cancer care and outcomes: where’s the rub? Surg Oncol Clin N Am [Internet]. NIH Public Access; 2012 [cited 2019 Dec 17];21:417–37, viii. Available from:
  23. National Academies of Science, Engineering and M. Appropriate use of advanced technologies for radiation therapy and surgery in oncology: Workshop summary.
  24. Mandelblatt JS, Kerner JF, Hadley J, Hwang Y-T, Eggert L, Johnson LE, et al. Variations in breast carcinoma treatment in older medicare beneficiaries. Cancer [Internet]. 2002 [cited 2019 Dec 17];95:1401–14. Available from:
  25. Freedman RA, He Y, Winer EP, Keating NL. Racial/Ethnic differences in receipt of timely adjuvant therapy for older women with breast cancer: are delays influenced by the hospitals where patients obtain surgical care? Health Serv Res [Internet]. Health Research & Educational Trust; 2013 [cited 2019 Dec 17];48:1669–83. Available from:
  26. Kodiyan J, Ashamalla M, Guirguis A, Ashamalla H. Improved Outcomes with Radiation Therapy in African Americans with Prostate Cancer. Int J Radiat Oncol [Internet]. Elsevier; 2019 [cited 2019 Dec 17];105:E287. Available from:
  27. Fang P, He W, Gomez D, Hoffman KE, Smith BD, Giordano SH, et al. Racial disparities in guideline-concordant cancer care and mortality in the United States. Adv Radiat Oncol [Internet]. Elsevier; 2018 [cited 2020 Jan 22];3:221–9. Available from:
  28. Stokes WA, Hendrix LH, Royce TJ, Allen IM, Godley PA, Wang AZ, et al. Racial differences in time from prostate cancer diagnosis to treatment initiation. Cancer [Internet]. John Wiley & Sons, Ltd; 2013 [cited 2019 Dec 17];119:2486–93. Available from:
  29. Mahal BA, Aizer AA, Ziehr DR, Hyatt AS, Sammon JD, Schmid M, et al. Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groups. Urology [Internet]. Elsevier; 2014 [cited 2019 Dec 17];84:386–92. Available from:
  30. Mahal BA, Chen Y-W, Muralidhar V, Mahal AR, Choueiri TK, Hoffman KE, et al. National sociodemographic disparities in the treatment of high-risk prostate cancer: Do academic cancer centers perform better than community cancer centers? Cancer [Internet]. 2016 [cited 2020 Jan 22];122:3371–7. Available from:
  31. Bradley CJ, Dahman B, Given CW. Treatment and survival differences in older Medicare patients with lung cancer as compared with those who are dually eligible for Medicare and Medicaid. J Clin Oncol [Internet]. American Society of Clinical Oncology; 2008 [cited 2019 Dec 17];26:5067–73. Available from:
  32. New Drugs at FDA: CDER’s New Molecular Entities and New Therapeutic Biological Products | FDA [Internet]. [cited 2019 Dec 17]. Available from:
  33. Aristizabal P, Singer J, Cooper R, Wells KJ, Nodora J, Milburn M, et al. Participation in Pediatric Oncology Research Protocols: Racial/ethnic, Language and Age-based Disparities. Pediatr Blood Cancer [Internet]. NIH Public Access; 2015 [cited 2019 Jun 20];62:1337. Available from:
  34. Unger JM, Vaidya R, Hershman DL, Minasian LM, Fleury ME. Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation. 2019;111:1–11.
  35. Kanapuru B, Singh H, Fashoyin-Aje LA, Myers A, Kim G, Farrell A, et al. FDA analysis of patient enrollment by region in clinical trials for approved oncological indications. J Clin Oncol [Internet]. American Society of Clinical Oncology; 2017 [cited 2019 Dec 17];35:2539–2539. Available from:
  36. Copur MS, Gulzow M, Zhou Y, Einspahr S, Scott J, Murphy L, et al. Impact of National Cancer Institute (NCI) Community Cancer Centers Program (NCCCP) and NCI Community Oncology Research Program (NCORP) on clinical trial (CT) activities in a community cancer center. J Clin Oncol [Internet]. American Society of Clinical Oncology; 2018 [cited 2019 Dec 17];36:e18500–e18500. Available from:
  37. Kim ES, Bruinooge SS, Roberts S, Ison G, Lin NU, Gore L, et al. Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement. J Clin Oncol [Internet]. American Society of Clinical Oncology; 2017 [cited 2020 Jan 27];35:3737–44. Available from:
  38. Ailawadhi S, Parikh K, Abouzaid S, Zhou Z, Tang W, Clancy Z, et al. Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis. Blood Adv [Internet]. 2019 [cited 2019 Dec 17];3:2986–94. Available from:
  39. Ikoma N, Cormier JN, Feig B, Du XL, Yamal J-M, Hofstetter W, et al. Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006-2014. Cancer [Internet]. 2018 [cited 2019 Dec 17];124:998–1007. Available from:
  40. Reeder-Hayes K, Peacock Hinton S, Meng K, Carey LA, Dusetzina SB. Disparities in Use of Human Epidermal Growth Hormone Receptor 2-Targeted Therapy for Early-Stage Breast Cancer. J Clin Oncol [Internet]. American Society of Clinical Oncology; 2016 [cited 2019 Dec 17];34:2003–9. Available from:
  41. Palazzo LL, Sheehan DF, Tramontano AC, Kong CY. Disparities and Trends in Genetic Testing and Erlotinib Treatment among Metastatic Non–Small Cell Lung Cancer Patients. Cancer Epidemiol Biomarkers Prev [Internet]. 2019 [cited 2019 Dec 17];28:926–34. Available from:
  42. Garon EB, Hellmann MD, Rizvi NA, Carcereny E, Leighl NB, Ahn M-J, et al. Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study. J Clin Oncol [Internet]. 2019 [cited 2019 Jul 15];JCO1900934. Available from:
  43. Al-Qurayshi Z, Crowther JE, Hamner JB, Ducoin C, Killackey MT, Kandil E. Disparities of Immunotherapy Utilization in Patients with Stage III Cutaneous Melanoma: A National Perspective. Anticancer Res [Internet]. 2018 [cited 2019 Dec 17];38:2897–901. Available from:
  44. Verma V, Haque W, Cushman TR, Lin C, Simone CB, Chang JY, et al. Racial and Insurance-related Disparities in Delivery of Immunotherapy-type Compounds in the United States. J Immunother [Internet]. 2019 [cited 2019 Dec 17];42:55–64. Available from:
  45. Halabi S, Dutta S, Tangen CM, Rosenthal M, Petrylak DP, Thompson IM, et al. Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel. J Clin Oncol [Internet]. 2019 [cited 2019 Dec 17];37:403–10. Available from:
  46. Sartor AO, Armstrong AJ, Ahaghotu C, McLeod DG, Cooperberg MR, Penson DF, et al. Overall survival (OS) of African-American (AA) and Caucasian (CAU) men who received sipuleucel-T for metastatic castration-resistant prostate cancer (mCRPC): Final PROCEED analysis. J Clin Oncol [Internet]. 2019 [cited 2019 Dec 17];37:5035–5035. Available from:
  47. George DJ, Heath EI, Sartor AO, Sonpavde G, Berry WR, Healy P, et al. Abi Race: A prospective, multicenter study of black (B) and white (W) patients (pts) with metastatic castrate resistant prostate cancer (mCRPC) treated with abiraterone acetate and prednisone (AAP). J Clin Oncol [Internet]. 2018 [cited 2019 Dec 17];36:LBA5009–LBA5009. Available from:
  48. Cykert S, Eng E, Walker P, Manning MA, Robertson LB, Arya R, et al. A system‐based intervention to reduce Black‐White disparities in the treatment of early stage lung cancer: A pragmatic trial at five cancer centers. Cancer Med [Internet]. 2019 [cited 2019 Dec 18];8:1095–102. Available from:
  49. Cykert S, Eng E, Manning MA, Robertson LB, Heron DE, Jones NS, et al. A Multi-faceted Intervention Aimed at Black-White Disparities in the Treatment of Early Stage Cancers: The ACCURE Pragmatic Quality Improvement trial. J Natl Med Assoc [Internet]. 2019 [cited 2019 Dec 18]; Available from:
  50. Hu B. Minorities Do Not Have Worse Outcomes for Diffuse Large B Cell Lymphoma (DLBCL) If Optimally Managed [Internet]. ASH; 2019 [cited 2019 Dec 18]. Available from:

References 301-350

  1. Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin [Internet]. American Cancer Society; 2019 [cited 2019 Jun 19];caac.21565. Available from:
  2. Centers for Disease Control and Prevention. Cancer Survivorship—United States, 1971–2001. Morbitity Mortal Wkly Rep. 2004;53:526–529.
  3. 2017 National Population Projections Datasets [Internet]. U.S. Census Bur. Washingt. DC. 2017. Available from:
  4. Vincent G. The next four decades the older population in the United States : 2010 to 2050. 2010; Available from:
  5. Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol [Internet]. American Society of Clinical Oncology; 2009 [cited 2019 Dec 17];27:2758–65. Available from:
  6. Kwan ML, Yao S, Lee VS, Roh JM, Zhu Q, Ergas IJ, et al. Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the Pathways Study. Breast Cancer Res Treat. Netherlands; 2016;159:119–29.
  7. Weaver KE, Geiger AM, Lu L, Case LD. Rural-urban disparities in health status among US cancer survivors. Cancer [Internet]. John Wiley & Sons, Ltd; 2013 [cited 2019 Jul 16];119:1050–7. Available from:
  8. Andrykowski MA, Aarts MJ, van de Poll-Franse L V., Mols F, Slooter GD, Thong MSY. Low socioeconomic status and mental health outcomes in colorectal cancer survivors: disadvantage? advantage? … or both? Psychooncology [Internet]. 2013 [cited 2019 Jun 19];22:2462–9. Available from:
  9. Litvak A, Batukbhai B, Russell SD, Tsai H-L, Rosner GL, Jeter SC, et al. Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer. Cancer [Internet]. 2018 [cited 2019 Jun 19];124:1904–11. Available from:
  10. Bhatnagar B, Gilmore S, Goloubeva O, Pelser C, Medeiros M, Chumsri S, et al. Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience. Springerplus [Internet]. Springer; 2014 [cited 2019 Dec 17];3:366. Available from:
  11. Keegan THM, Li Q, Steele A, Alvarez EM, Brunson A, Flowers CR, et al. Sociodemographic disparities in the occurrence of medical conditions among adolescent and young adult Hodgkin lymphoma survivors. Cancer Causes Control. Netherlands; 2018;29:551–61.
  12. Ashing-Giwa KT. The contextual model of HRQoL: A paradigm for expanding the HRQoL framework. Qual Life Res [Internet]. Springer; 2005 [cited 2019 Dec 17];14:297–307. Available from:
  13. Barile JP, Reeve BB, Smith AW, Zack MM, Mitchell SA, Kobau R, et al. Monitoring population health for Healthy People 2020: evaluation of the NIH PROMIS® Global Health, CDC Healthy Days, and satisfaction with life instruments. Qual Life Res [Internet]. 2013 [cited 2019 Dec 17];22:1201–11. Available from:
  14. Weaver KE, Forsythe LP, Reeve BB, Alfano CM, Rodriguez JL, Sabatino SA, et al. Mental and Physical Health-Related Quality of Life among U.S. Cancer Survivors: Population Estimates from the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev [Internet]. 2012 [cited 2019 Dec 17];21:2108–17. Available from:
  15. Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci [Internet]. 2003 [cited 2019 Dec 17];58:82–91. Available from:
  16. Williams K, Jackson SE, Beeken RJ, Steptoe A, Wardle J. The impact of a cancer diagnosis on health and well-being: a prospective, population-based study. Psychooncology [Internet]. Wiley-Blackwell; 2016 [cited 2019 Dec 17];25:626–32. Available from:
  17. Ashing-Giwa KT, Tejero JS, Kim J, Padilla G V., Hellemann G. Examining predictive models of HRQOL in a population-based, multiethnic sample of women with breast carcinoma. Qual Life Res [Internet]. Springer; 2007 [cited 2019 Dec 17];16:413–28. Available from:
  18. Hao Y, Landrine H, Smith T, Kaw C, Corral I, Stein K. Residential segregation and disparities in health-related quality of life among Black and White cancer survivors. Heal Psychol [Internet]. 2011 [cited 2019 Dec 17];30:137–44. Available from:
  19. Ye J, Shim R, Garrett SL, Daniels E. Health-related quality of life in elderly black and white patients with cancer: results from Medicare managed care population. Ethn Dis [Internet]. NIH Public Access; 2012 [cited 2019 Dec 17];22:302–7. Available from:
  20. Pinheiro LC, Samuel CA, Reeder-Hayes KE, Wheeler SB, Olshan AF, Reeve BB. Understanding racial differences in health-related quality of life in a population-based cohort of breast cancer survivors. Breast Cancer Res Treat [Internet]. 2016 [cited 2019 Dec 17];159:535–43. Available from:
  21. Samuel CA, Pinheiro LC, Reeder-Hayes KE, Walker JS, Corbie-Smith G, Fashaw SA, et al. To be young, Black, and living with breast cancer: a systematic review of health-related quality of life in young Black breast cancer survivors. Breast Cancer Res Treat [Internet]. Springer; 2016 [cited 2019 Dec 17];160:1–15. Available from:
  22. Yanez B, Thompson EH, Stanton AL. Quality of life among Latina breast cancer patients: a systematic review of the literature. J Cancer Surviv [Internet]. Springer; 2011 [cited 2019 Dec 17];5:191–207. Available from:
  23. Beebe-Dimmer JL, Albrecht TL, Baird TE, Ruterbusch JJ, Hastert T, Harper FWK, et al. The Detroit Research on Cancer Survivors (ROCS) Pilot Study: A focus on outcomes after cancer in a racially-diverse patient population. Cancer Epidemiol Biomarkers Prev [Internet]. American Association for Cancer Research; 2018 [cited 2019 Dec 17];28:cebp.0123.2018. Available from:
  24. Hastert TA, Kyko JM, Reed AR, Harper FWK, Beebe-Dimmer JL, Baird TE, et al. Financial Hardship and Quality of Life among African American and White Cancer Survivors: The Role of Limiting Care Due to Cost. Cancer Epidemiol Biomarkers Prev [Internet]. American Association for Cancer Research; 2019 [cited 2019 Dec 17];28:1202–11. Available from:
  25. Miller AM, Ashing KT, Modeste NN, Herring RP, Sealy D-AT. Contextual factors influencing health-related quality of life in African American and Latina breast cancer survivors. J Cancer Surviv [Internet]. NIH Public Access; 2015 [cited 2019 Dec 17];9:441–9. Available from:
  26. Rao D, Debb S, Blitz D, Choi SW, Cella D. Racial/Ethnic differences in the health-related quality of life of cancer patients. J Pain Symptom Manage [Internet]. NIH Public Access; 2008 [cited 2019 Dec 17];36:488–96. Available from:
  27. Ashing-Giwa KT, Lim J, Tang J. Surviving cervical cancer: Does health-related quality of life influence survival? Gynecol Oncol [Internet]. Academic Press; 2010 [cited 2019 Dec 17];118:35–42. Available from:
  28. Bernard DSM, Farr SL, Fang Z. National Estimates of Out-of-Pocket Health Care Expenditure Burdens Among Nonelderly Adults With Cancer: 2001 to 2008. J Clin Oncol [Internet]. 2011 [cited 2019 Dec 17];29:2821–6. Available from:
  29. Ekwueme DU, Zhao J, Rim SH, Moor JS De, Zheng Z, Khushalani JS, et al. Annual Out-of-Pocket Expenditures and Financial Hardship Among Cancer Survivors Aged 18 – 64 Years — United States , 2011 – 2016. 2019;68:2011–6.
  30. Bestvina CM, Zullig LL, Rushing C, Chino F, Samsa GP, Altomare I, et al. Patient-Oncologist Cost Communication, Financial Distress, and Medication Adherence. J Oncol Pract [Internet]. 2014 [cited 2019 Dec 17];10:162–7. Available from:
  31. Ramsey SD, Bansal A, Fedorenko CR, Blough DK, Overstreet KA, Shankaran V, et al. Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer. J Clin Oncol [Internet]. American Society of Clinical Oncology; 2016 [cited 2019 Dec 17];34:980–6. Available from:
  32. Zafar SY, McNeil RB, Thomas CM, Lathan CS, Ayanian JZ, Provenzale D. Population-Based Assessment of Cancer Survivors’ Financial Burden and Quality of Life: A Prospective Cohort Study. J Oncol Pract [Internet]. 2015 [cited 2019 Dec 17];11:145–50. Available from:
  33. Pisu M, Kenzik KM, Oster RA, Drentea P, Ashing KT, Fouad M, et al. Economic hardship of minority and non-minority cancer survivors 1 year after diagnosis: another long-term effect of cancer? Cancer [Internet]. NIH Public Access; 2015 [cited 2019 Dec 18];121:1257–64. Available from:
  34. Financial Toxicity and Cancer Treatment (PDQ®)—Health Professional Version – National Cancer Institute [Internet]. [cited 2019 Jun 20]. Available from:
  35. Zajacova A, Dowd JB, Schoeni RF, Wallace RB. Employment and income losses among cancer survivors: Estimates from a national longitudinal survey of American families. Cancer [Internet]. 2015 [cited 2019 Dec 18];121:4425–32. Available from:
  36. Spencer JC, Rotter JS, Eberth JM, Zahnd WE, Vanderpool RC, Ko LK, et al. Employment changes following breast cancer diagnosis: the effects of race and place. JNCI J Natl Cancer Inst [Internet]. 2019 [cited 2019 Dec 18]; Available from:
  37. Bradley CJ, Wilk A. Racial differences in quality of life and employment outcomes in insured women with breast cancer. J Cancer Surviv [Internet]. NIH Public Access; 2014 [cited 2019 Dec 18];8:49–59. Available from:
  38. Veenstra CM, Wallner LP, Jagsi R, Abrahamse P, Griggs JJ, Bradley CJ, et al. Long-Term Economic and Employment Outcomes Among Partners of Women With Early-Stage Breast Cancer. J Oncol Pract [Internet]. American Society of Clinical Oncology; 2017 [cited 2019 Dec 18];13:e916–26. Available from:
  39. Minkler M, Blackwell AG, Thompson M, Tamir H. Community-based participatory research: implications for public health funding. Am J Public Health [Internet]. American Public Health Association; 2003 [cited 2019 Dec 18];93:1210–3. Available from:
  40. Wong CHIH, Siah KWEI, Lo AW. Estimation of clinical trial success rates and related. 2018;1–14.
  41. Clinical Development Success Rates. 2016;
  42. NCI-MATCH: More Labs, New Arms, Initial Findings – National Cancer Institute [Internet]. [cited 2019 Dec 18]. Available from:
  43. Kim ES, Herbst RS, Wistuba II, Lee JJ, Blumenschein GR, Tsao A, et al. The BATTLE trial: personalizing therapy for lung cancer. Cancer Discov [Internet]. American Association for Cancer Research; 2011 [cited 2019 Dec 18];1:44–53. Available from:
  44. Von Hoff DD, Stephenson JJ, Rosen P, Loesch DM, Borad MJ, Anthony S, et al. Pilot study using molecular profiling of patients’ tumors to find potential targets and select treatments for their refractory cancers. J Clin Oncol [Internet]. 2010 [cited 2019 Dec 18];28:4877–83. Available from:
  45. Sicklick JK, Kato S, Okamura R, Schwaederle M, Hahn ME, Williams CB, et al. Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study. Nat Med [Internet]. Nature Publishing Group; 2019 [cited 2019 Jun 19];25:744–50. Available from:
  46. Kehl KL, Lathan CS, Johnson BE, Schrag D. Race, Poverty, and Initial Implementation of Precision Medicine for Lung Cancer. JNCI J Natl Cancer Inst [Internet]. 2019 [cited 2019 Dec 18];111:431–4. Available from:
  47. Singal G, Miller PG, Agarwala V, Li G, Kaushik G, Backenroth D, et al. Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database. Jama. 2019;321:1391–9.
  48. Kurian AW, Ward KC, Howlader N, Deapen D, Hamilton AS, Mariotto A, et al. Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients. J Clin Oncol [Internet]. 2019 [cited 2019 Dec 18];37:1305–15. Available from:
  49. All T, Investigators P, All T, Obama PB, Initiative PM, Institutes N, et al. Spe ci a l R e p or t The “All of Us” Research Program. 2019;
  50. NIH, PCF launch study on prostate cancer in black men – National Cancer Institute [Internet]. [cited 2019 Dec 18]. Available from:

References 351-398

  1. Obermeyer Z, Powers B, Vogeli C, Mullainathan S. Dissecting racial bias in an algorithm used to manage the health of populations. Science [Internet]. American Association for the Advancement of Science; 2019 [cited 2019 Dec 18];366:447–53. Available from:
  2. Shcherbina A, Mattsson C, Waggott D, Salisbury H, Christle J, Hastie T, et al. Accuracy in Wrist-Worn, Sensor-Based Measurements of Heart Rate and Energy Expenditure in a Diverse Cohort. J Pers Med [Internet]. Multidisciplinary Digital Publishing Institute; 2017 [cited 2019 Dec 18];7:3. Available from:
  3. Dreachslin JL. Conducting effective focus groups in the context of diversity: theoretical underpinnings and practical implications. Qual Health Res [Internet]. Sage PublicationsSage CA: Thousand Oaks, CA; 1998 [cited 2019 Dec 18];8:813–20. Available from:
  4. Rock D, Grant H. Why Diverse Teams Are Smarter. Harvard Bus Rev Digit Artic. 2016;p2-4. 3p.
  5. Marrast LM, Zallman L, Woolhandler S, Bor DH, McCormick D. Minority Physicians’ Role in the Care of Underserved Patients. JAMA Intern Med [Internet]. American Medical Association; 2014 [cited 2019 Dec 18];174:289. Available from:
  6. Hunt V, Prince S, Dixon-Fyle S, Yee L. Delivering through Diversity. Mckinsey Co [Internet]. 2018;42. Available from: functions/organization/our insights/delivering through diversity/delivering-through-diversity_full-report.ashx
  7. National Conference of State Legislatures. Racial and Ethnic Health Disparities: Workforce Diversity. 2014;1–3.
  8. Heggeness ML, Evans L, Pohlhaus JR, Mills SL. Measuring Diversity of the National Institutes of Health-Funded Workforce. Acad Med [Internet]. 2016 [cited 2020 Jan 27];91:1164–72. Available from:
  9. Domina T, McEachin A, Penner A, Penner E. Aiming High and Falling Short. Educ Eval Policy Anal [Internet]. 2015 [cited 2019 Dec 18];37:275–95. Available from:
  10. The Condition of Education – Population Characteristics and Economic Outcomes – Population Characteristics – Educational Attainment of Young Adults – Indicator May (2019) [Internet]. [cited 2019 Dec 18]. Available from:
  11. Valantine HA, Lund PK, Gammie AE. From the NIH: A Systems Approach to Increasing the Diversity of the Biomedical Research Workforce. CBE Life Sci Educ [Internet]. American Society for Cell Biology; 2016 [cited 2020 Jan 27];15. Available from:
  12. Lett LA, Murdock HM, Orji WU, Aysola J, Sebro R. Trends in Racial/Ethnic Representation Among US Medical Students. JAMA Netw Open [Internet]. 2019 [cited 2019 Dec 18];2:e1910490. Available from:
  13. Komaromy M, Grumbach K, Drake M, Vranizan K, Lurie N, Keane D, et al. The Role of Black and Hispanic Physicians in Providing Health Care for Underserved Populations. N Engl J Med [Internet]. Massachusetts Medical Society ; 1996 [cited 2019 Dec 18];334:1305–10. Available from:
  14. Graziani GC, Augenblick N, Bulow J, Casey K, Chandrasekhar A, Chetty R, et al. Does Diversity Matter For Health? Am Econ Rev [Internet]. 2019;109:4071–111. Available from:
  15. Cooper-Patrick L, Gallo JJ, Gonzales JJ, Vu HT, Powe NR, Nelson C, et al. Race, Gender, and Partnership in the Patient-Physician Relationship. JAMA [Internet]. American Medical Association; 1999 [cited 2019 Dec 18];282:583. Available from:
  16. Charlot M, Santana MC, Chen CA, Bak S, Heeren TC, Battaglia TA, et al. Impact of patient and navigator race and language concordance on care after cancer screening abnormalities. Cancer [Internet]. NIH Public Access; 2015 [cited 2019 Dec 18];121:1477–83. Available from:
  17. Noah BA. The Participation of Underrepresented Minorities in Clinical Research [Internet]. 2003 [cited 2019 Dec 18]. Available from:
  18. Dall T, Reynolds R, Jones K, Chakrabarti R, Iacobucci W. The Complexities of Physician Supply and Demand: Projections from 2017 to 2032. Assoc Am Med Coll [Internet]. 2019;86. Available from:
  19. Heggeness ML, Gunsalus KTW, Pacas J, McDowell G. The new face of US science. Nature [Internet]. 2017 [cited 2019 Dec 18];541:21–3. Available from:
  20. Duncan GA, Lockett A, Villegas LR, Almodovar S, Gomez JL, Flores SC, et al. National Heart, Lung, and Blood Institute Workshop Summary: Enhancing Opportunities for Training and Retention of a Diverse Biomedical Workforce. Ann Am Thorac Soc [Internet]. American Thoracic Society; 2016 [cited 2019 Dec 18];13:562–7. Available from:
  21. Nikaj S, Roychowdhury D, Lund PK, Matthews M, Pearson K. Examining trends in the diversity of the U.S. National Institutes of Health participating and funded workforce. FASEB J. 2018;32:6410–22.
  22. Ginther DK, Kahn S, Schaffer WT. Gender, Race/Ethnicity, and National Institutes of Health R01 Research Awards: Is There Evidence of a Double Bind for Women of Color? Acad Med [Internet]. NIH Public Access; 2016 [cited 2019 Dec 18];91:1098–107. Available from:
  23. Winkfield KM, Flowers CR, Patel JD, Rodriguez G, Robinson P, Agarwal A, et al. American Society of Clinical Oncology strategic plan for increasing racial and ethnic diversity in the oncology workforce. J Clin Oncol. 2017;35:2576–9.
  24. Lett LA, Orji WU, Sebro R. Declining racial and ethnic representation in clinical academic medicine: A longitudinal study of 16 US medical specialties. PLoS One [Internet]. Public Library of Science; 2018 [cited 2019 Dec 18];13:e0207274. Available from:
  25. 2019 FACTS: Enrollment, Graduates, and MD-PhD Data | AAMC [Internet]. [cited 2019 Dec 18]. Available from:
  26. Behera A, Tan J, Erickson H. Diversity and the next-generation physician-scientist. J Clin Transl Sci [Internet]. Cambridge University Press; 2019 [cited 2019 Dec 18];3:47–9. Available from:
  27. Mukesh K. Jain, M.D., Vivian G. Cheung, M.D., Paul J. Utz, M.D., Brian K. Kobilka, M.D., Tadataka Yamada, M.D., and Robert Lefkowitz MD. Saving the Endangered Physician-Scientist — A Plan for Accelerating Medical Breakthroughs Mukesh. N Engl J Med. 2019;381:397–9.
  28. Carethers JM. Diversification in the medical sciences fuels growth of physician-scientists. J Clin Invest [Internet]. American Society for Clinical Investigation; 2019 [cited 2020 Jan 23];129:5051–4. Available from:
  29. Smiley RA, Lauer P, Bienemy C, Berg JG, Shireman E, Reneau KA, et al. The 2017 National Nursing Workforce Survey. J Nurs Regul [Internet]. Elsevier Masson SAS; 2018;9:S1–88. Available from:
  30. Garcia RI, Blue Spruce G, Sinkford JC, Lopez MJ, Sullivan LW. Workforce diversity in dentistry – current status and future challenges. J Public Health Dent [Internet]. John Wiley & Sons, Ltd (10.1111); 2017 [cited 2019 Dec 18];77:99–104. Available from:
  31. Industry Documents Library | UCSF Library [Internet]. [cited 2020 Jan 27]. Available from:
  32. Substance Abuse and Mental Health Services Administration. Results from the 2016 National Survey on Drug Use and Health: Detailed Tables. Cent Behav Stat Qual [Internet]. 2017;1–2889. Available from:
  33. U.S. Food and Drug Administration. Preliminary scientific evaluation of the possible public health effects of menthol versus nonmenthol cigarettes. US Dep Heal Hum Serv [Internet]. 2013; Available from:
  34. Citizen Petition Asking the U.S. Food and Drug Administration to Prohibit Menthol as a Characterizing Flavor in Cigarettes. 2013; Available from:
  35. Uppal S, Chapman C, Spencer RJ, Jolly S, Maturen K, Rauh-Hain JA, et al. Association of Hospital Volume With Racial and Ethnic Disparities in Locally Advanced Cervical Cancer Treatment. Obstet Gynecol [Internet]. 2017 [cited 2020 Jan 27];129:295–304. Available from:
  36. REACH Program Impact | DNPAO | CDC [Internet]. [cited 2020 Jan 27]. Available from:
  37. NIH launches largest-ever study of breast cancer genetics in black women | National Institutes of Health (NIH) [Internet]. [cited 2020 Jan 27]. Available from:
  38. Eighth Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services – US Preventive Services Task Force [Internet]. [cited 2020 Jan 27]. Available from:
  39. Aldrich MC, Mercaldo SF, Sandler KL, Blot WJ, Grogan EL, Blume JD. Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers. JAMA Oncol [Internet]. 2019 [cited 2020 Jan 27];5:1318. Available from:
  40. Preventive care benefits for adults | [Internet]. [cited 2020 Jan 27]. Available from:
  41. NCI. NCI Recommended Protocol Text and Guidance based on Joint Recommendations of the American Society of Clinical Oncology (ASCO) and Friends of Cancer Research (Friends). 2018;1–9.
  42. U.S. Department of Health and Human Services Administration Food and Drug. Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs Draft Guidance for Industry. 2019;June 2019:1–18. Available from:
  43. Barriers to Patient Enrollment in Therapeutic Clinical Trials for Cancer | American Cancer Society Cancer Action Network [Internet]. [cited 2020 Jan 27]. Available from:
  44. The Henry J Kaiser Family Foundation. Key Facts about the Uninsured Population. Henry J Kaiser Fam Found [Internet]. 2016;1–14. Available from:
  45. Graves JA, Swartz K. Effects of Affordable Care Act Marketplaces and Medicaid Eligibility Expansion on Access to Cancer Care. Cancer J [Internet]. 2017 [cited 2020 Jan 27];23:168–74. Available from:
  46. Choi SK, Adams SA, Eberth JM, Brandt HM, Friedman DB, Tucker-Seeley RD, et al. Medicaid Coverage Expansion and Implications for Cancer Disparities. Am J Public Health [Internet]. 2015 [cited 2020 Jan 27];105:S706–12. Available from:
  47. Eguia E, Cobb AN, Kothari AN, Molefe A, Afshar M, Aranha G V, et al. Impact of the Affordable Care Act (ACA) Medicaid Expansion on Cancer Admissions and Surgeries. Ann Surg [Internet]. NIH Public Access; 2018 [cited 2020 Jan 27];268:584–90. Available from:
  48. Tarazi WW, Bradley CJ, Harless DW, Bear HD, Sabik LM. Medicaid expansion and access to care among cancer survivors: a baseline overview. J Cancer Surviv [Internet]. 2016 [cited 2020 Jan 27];10:583–92. Available from: